Brokerage Reports | Latest & Breaking News on Brokerage Reports | Photos, Videos, Breaking Stories and Articles on Brokerage Reports

Buy Dr Lal Pathlabs; target of Rs 3100: Emkay

Emkay is bullish on Dr Lal Pathlabs has recommended buy rating on the stock with a target price of Rs 3100 in its research report dated July 20, 2025.

Hold Dr Lal Pathlabs: target of Rs 2,900: ICICI Securities

ICICI Securities recommended hold rating on Dr Lal Pathlabs with a target price of Rs 2,900 in its research report dated April 26, 2025.

Buy Dr Lal Pathlabs; target of Rs 3100: Emkay Global Financial

Emkay Global Financial recommended buy rating on Dr Lal Pathlabs with a target price of Rs 3100 in its research report dated April 26, 2025.

Buy Dr Lal Pathlabs; target of Rs 3250: Emkay Global Financial

Emkay Global Financial is bullish on Dr Lal Pathlabs has recommended buy rating on the stock with a target price of Rs 3250 in its research report dated January 30, 2025.

Hold Dr Lal Pathlabs; target of Rs 3100: ICICI Securities

ICICI Securities recommended hold rating on Dr Lal Pathlabs with a target price of Rs 3100 in its research report dated October 24, 2024.

Hold Dr Lal Pathlabs; target of Rs 3,240: ICICI Securities

ICICI Securities recommended hold rating on Dr Lal Pathlabs with a target price of Rs 3,240 in its research report dated August 08, 2024.

Buy Dr Lal Pathlabs; target of Rs 2800: Emkay

Emkay is bullish on Dr Lal Pathlabs has recommended buy rating on the stock with a target price of Rs 2800 in its research report dated May 10, 2024.

Hold Dr. Lal PathLabs; target of Rs 1995: Geojit

Geojit recommended recommended hold rating on Dr. Lal PathLabs with a target price of Rs 1995 in its research report dated August 06, 2020.

Sell Dr. Lal PathLabs; target of Rs 1006: Prabhudas Lilladher

Prabhudas Lilladher is bearish on Dr. Lal PathLabs has recommended sell rating on the stock with a target price of Rs 1006 in its research report dated August 03, 2020.

Sell Dr. Lal PathLabs; target of Rs 895: Prabhudas Lilladher

Prabhudas Lilladher is bearish on Dr. Lal PathLabs has recommended sell rating on the stock with a target price of Rs 895 in its research report dated May 19, 2020.

Accumulate Dr. Lal PathLabs; target of Rs 1120: Prabhudas Lilladher

Prabhudas Lilladher recommended accumulate rating on Dr. Lal PathLabs with a target price of Rs 1120 in its research report dated August 14, 2019.

Accumulate Dr. Lal PathLabs; target of Rs 1070: Prabhudas Lilladher

Prabhudas Lilladher recommended accumulate rating on Dr. Lal PathLabs with a target price of Rs 1070 in its research report dated February 11, 2019.

Accumulate Dr. Lal PathLabs; target of Rs 1009: Prabhudas Lilladher

Prabhudas Lilladher recommended accumulate rating on Dr. Lal PathLabs with a target price of Rs 1009 in its research report dated November 07, 2018.

Accumulate Dr. Lal PathLabs; target of Rs 1009: Prabhudas Lilladher

Prabhudas Lilladher recommended accumulate rating on Dr. Lal PathLabs with a target price of Rs 1009 in its research report dated May 14, 2018.

Dr Lal, Rallis India & Ceat among 5 safe midcaps you can bet on

All the five companies are mid cap (market capitalisation between Rs 1000 crore and Rs 10,000 crore) and have superior fundamentals (ROCE and ROE consistently above 15% for the past 3 years). Barring one, the remaining four have underperformed the markets’ rally in the past six months.

Buy Dr. Lal Pathlabs; target of Rs 1230: Edelweiss

Edelweiss is bullish on Dr. Lal Pathlabs has recommended buy rating on the stock with a target price of Rs 1230 in its research report dated February 02, 2017.